Reflucalm
Oral gel for the treatment of mild gastroesophageal reflux symptoms
REFLUCALM is a medical device (MD) in oral gel form, designed for the treatment of mild symptoms of Gastroesophageal Reflux Disease (GERD). It is specifically indicated for patients experiencing mild reflux symptoms once or twice a month.
Its formulation acts with a mechanical barrier effect aimed at blocking gastroesophageal acid reflux. The main components include:
- Sodium Alginate, whose role is to exert a targeted mechanical block of gastroesophageal reflux.
- Sodium Bicarbonate and Calcium Carbonate, which help neutralize acidity and strengthen the anti-reflux barrier.
- Gum Arabic and Xanthan Gum, which provide the gelatinous consistency (the product is described as “Oral solution” in the catalog, but in a form that ensures the barrier effect).
Therapeutic indications:
- Mild Gastroesophageal Reflux Disease (GERD).
- Treatment for patients experiencing mild acid reflux symptoms once or twice a month.
- Symptoms associated with acid reflux such as burning and heartburn (not explicitly mentioned in the text, but implicit for GERD).
- Formation of a barrier effect on the gastroesophageal tract.
FarmaImpresa Group, a certified manufacturer of medical devices, dietary supplements, and dermocosmetics, offers REFLUCALM ready for commercialization (ready to market) or available in private label, with full technical and regulatory support.
